Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved ...Middle East

PR Newswire - News
Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved
GOTHENBURG, Sweden, March 22, 2021 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that a notice that a Clinical Use Patent for the drug candidate arfolitixorin will be approved in Europe. The patent covers a dose regimen for...

Hence then, the article about isofol receives notice that clinical use patent in europe for drug candidate arfolitixorin will be approved was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News